Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  News  >  Sectors  >  Healthcare

News : Sectors

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors
08/19ASTRAZENECA : to Supply Australia with Covid-19 Vaccine if Trials Succeed
DJ
08/19GALAPAGOS : Gilead Shares Fall as FDA Seeks More Filgotinib Data
DJ
08/19MYLAN N : Launches First U.S. Generic of Biogen MS Drug Tecfidera
DJ
08/19Gilead shares slide after FDA knocks back rheumatoid arthritis drug
RE
08/19MERCK : Keytruda Meets Main Endpoints in Esophageal Cancer Study
DJ
08/19JOHNSON & JOHNSON : to Buy Momenta Pharmaceuticals for $6.5 Billion
DJ
08/19CARL ZEISS MEDITEC AG : Independant Research maintains a Sell rating
MD
08/19Coronavirus Pandemic Slashes Donations of Lifesaving Plasma
DJ
08/19GILEAD SCIENCES : Drug costs for COVID-19 patients plunge at U.S. hospitals, but may rise
RE
08/19German institute says coronavirus vaccinations could start in early 2021
RE
08/19German institute says coronavirus vaccinations could start in early 2021
RE
08/19REGENERON PHARMACEUTICALS : Enlists Swiss Rival Roche to Help Make Covid-19 Drug
DJ
08/19Australia's CSL eyes COVID-19 vaccine by mid-2021 as it beats profit forecast
RE
08/18Takeda preparing to sell Japan consumer health unit to Blackstone - Kyodo
RE
08/18GILEAD SCIENCES : Filgotinib, a Collaboration With Galapagos, Gets Complete Response Letter for Application From FDA
DJ
Discover
08/18Australia's CSL eyes COVID-19 vaccine by mid-2021 as it beats profit forecast
RE
08/18CSL : Australia's CSL full-year profit jumps 17% on higher demand for drugs
RE
08/18Australia signs deal with AstraZeneca for possible COVID-19 vaccine
RE
08/18CSL : Fiscal Year Net Profit Rises Amid Strong Immunoglobulin, Flu-Vaccine Sales
DJ
08/18NICHIIGAKKAN : Bain Capital clinches $1.2 billion deal for Japan's Nichiigakkan after fending off higher bid
RE
08/18Vanda's experimental COVID-19 drug shows promise in interim trial data
RE
08/18ELI LILLY AND : Innovent Set Global Expansion of Tyvyt Agreement
DJ
08/18SANOFI : UBS remains its Buy rating
MD
08/18NOVO NORDISK : UBS sticks Neutral
MD
08/18NOVARTIS AG : Goldman Sachs maintains a Buy rating
MD
08/18NOVARTIS AG : JP Morgan keeps a Sell rating
MD
08/18NOVARTIS : Gilenya Dosage Regimen Patent Upheld in US Court Decision
DJ
08/18BIOCON : India interior minister back in hospital after recovering from COVID-19
RE
08/18ASTRAZENECA : Imfinzi Granted FDA Priority Review for Fixed-Dose Use
DJ
08/18EVOTEC : Baader Bank reiterates its Buy rating
MD
08/18Sanofi Buys MS-Drug Development Partner -- WSJ
DJ
08/18SANOFI : Credit Suisse reiterates its Buy rating
MD
08/18STRATEC BIOMEDICAL SYSTEMS AG : Receives a Buy rating from Berenberg
MD
08/17NICHIIGAKKAN : Bain Capital clinches $1.2 bln deal for Japan's Nichiigakkan after fending off higher bid
RE
08/17GILEAD SCIENCES : Tango Therapeutics Expand Strategic Oncology Collaboration
DJ
08/17FISHER & PAYKEL HEALTHCARE : F&P Healthcare Raises Earnings Forecast, Pandemic Boosts Sales --Update
DJ
08/17FISHER & PAYKEL HEALTHCARE : F&P Healthcare Raises Earnings Forecast, Pandemic Boosts Device Sales
DJ
08/17NOVARTIS : U.S. court upholds patent for Novartis MS drug Gilenya
RE
08/17NOVARTIS : says U.S. court upholds validity of Gilenya dosage regimen patent
RE
08/17Sanofi to Buy U.S. Developer of Multiple Sclerosis Treatment -- 2nd Update
DJ
08/17QUEST DIAGNOSTICS : Anthem, Quest Diagnostics in Strategic Relationship
DJ
08/17BRISTOL MYERS SQUIBB : Licenses Dragonfly Therapeutics Program
DJ
08/17MORPHOSYS : Barclays reaffirms its Neutral rating
MD
08/17Kymera Therapeutics Sets IPO at 7.36 Million Shares, Sees Pricing at $16-$18 Each
DJ
08/17Sanofi to Buy U.S. Developer of Multiple Sclerosis Treatment--Update
DJ
08/17SANOFI : Receives a Buy rating from JP Morgan
MD
08/17SANOFI : Goldman Sachs gives a Buy rating
MD
08/17SANOFI : to Acquire US Company Principia Biopharma for $3.68 Billion -- Update
DJ
08/17SANOFI : Correction to Sanofi Article
DJ
08/17SANOFI : to Acquire US Company Principia Biopharma for $3.68 Billion
DJ
08/17MORPHOSYS : Goldman Sachs remains Neutral
MD
08/17NICHIIGAKKAN : Baring Private Equity makes $1.4 billion counter bid for Bain target Nichiigakkan
RE
08/16NICHIIGAKKAN : Baring Private Equity says it is offering to buy Japan's Nichiigakkan at 2,000 yen per share
RE
08/14COVID-19 vaccine developer CureVac shares more than triple after U.S. debut
RE
08/14Argentine firm behind AstraZeneca COVID vaccine Latam production sees April/May launch
RE
08/14COVID-19 vaccine developer CureVac shares more than triple after U.S. debut
RE
08/14GLAXOSMITHKLINE : COVID-19 vaccine developer CureVac shares more than triple after U.S. debut
RE
08/14EU Secures Coronavirus Vaccine Deal With AstraZeneca
DJ
08/14EU agrees first COVID-19 vaccine deal with AstraZeneca in WHO blow
RE
08/14ASTRAZENECA : U.S. to make coronavirus strain for possible human challenge trials
RE
08/14NOVO NORDISK : Kepler Cheuvreux reaffirms its Neutral rating
MD
08/14STRATEC BIOMEDICAL SYSTEMS AG : Warburg Research sticks Neutral
MD
08/14FRESENIUS SE : JP Morgan maintains a Buy rating
MD
08/13Coronavirus vaccine developer CureVac raises $213 million in IPO
RE
08/13AstraZeneca set to start making 400 million COVID-19 vaccines for Latam early in 2021
RE
Discover
08/13THERMO FISHER SCIENTIFIC : Drops $11.2 Billion Qiagen Bid -- Update
DJ
08/13ASTRAZENECA : says could begin COVID-19 vaccine production early in 2021
RE
08/13ASTRAZENECA : says could begin COVID-19 vaccine production early in 2021
RE
08/13STRATEC BIOMEDICAL SYSTEMS AG : Kepler Cheuvreux keeps its Buy rating
MD
08/13STRATEC BIOMEDICAL SYSTEMS AG : Warburg Research sticks Neutral
MD
Prev.3  4  5  6  7   8  9  10  11  12Next